Adenocarcinoma of the lung: Difference between revisions

Jump to navigation Jump to search
Michael (talk | contribs)
Michael (talk | contribs)
 
(One intermediate revision by the same user not shown)
Line 249: Line 249:
NEGATIVE: p40.
NEGATIVE: p40.


The findings are in keeping with lepidic pattern adenocarcinoma.  The differential diagnosis includes: (1) adenocarcinoma in situ, (2) lepidic pattern adenocarcinoma, and (3) invasive adenocarcinoma.
The findings are in keeping with lepidic pattern adenocarcinoma; the differential diagnosis includes: (1) adenocarcinoma in situ, (2) minimally invasive adenocarcinoma, and (3) invasive adenocarcinoma.


Lung biomarkers (EGFR, ALK, PDL1, ROS1) have been ordered.
Lung biomarkers (EGFR, ALK, PDL1, ROS1) have been ordered.